Picture of Celltrion Healthcare Co logo

091990 — Celltrion Healthcare Co News Story

0.000.00%
kr flag iconLast trade - 00:00
HealthcareAdventurousLarge Cap

Brief: Teva And Celltrion Announce The Availability Of Truxima

Nov 7 (Reuters) - Celltrion Inc  068270.KS :
    * TEVA AND CELLTRION ANNOUNCE THE AVAILABILITY OF TRUXIMA®
(RITUXIMAB-ABBS) INJECTION, THE FIRST BIOSIMILAR TO RITUXAN®
(RITUXIMAB) IN THE UNITED STATES
    * TEVA PHARMACEUTICAL - TRUXIMA IS BEING MADE AVAILABLE
THROUGH
PRIMARY WHOLESALERS AT A WAC OF $845.55 FOR 100MG VIAL AND
$4227.75 FOR 500MG VIAL

Source text for Eikon:  ID:nBw78jZ8Sa 
Further company coverage:  068270.KS 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Celltrion Healthcare Co

See all news